
The Painless Research Foundation concentrates its philanthropic support on biomedical research at leading academic medical centers, with an especially strong, recurring commitment to UCSF. Nearly all of its funding is directed to research grants rather than community programs, indicating a focus on advancing clinical or basic science investigations (likely related to pain given the foundation name). Grants are large relative to the foundation's small portfolio and target established research institutions.
Highly concentrated: few, large research grants with repeat funding to a single primary grantee (UCSF); occasional support to other elite hospitals. Emphasis is on institutional research grants rather than many small or grassroots awards.
Painless Research Foundation’s recent giving is anchored by repeated research support to UC Regents/UCSF, including a $100,000 research grant in 2025, an $87,000 grant in 2023, and an $83,500 grant in 2024. That pattern points to a funder that favors sustained, project-based support for academic medical research rather than one-off awards. The foundation’s active programs center on pain-related biomedical research, therapy development, and related education, with stated attention to cancer pain, neuropathic pain, post-operative pain, chronic pain, inflammatory disorders, and endocrine disorders. The foundation also supports hospital-based research beyond UCSF, as shown by a 2025 grant to Mass General Hospital for research. Grants are directed to established research institutions and labs, reflecting a focus on clinical or translational work in settings that can advance evidence generation and therapy development. Across the available grant record, the pattern is narrow and consistent: research support for institutions conducting pain-focused science.
Pain-related biomedical research is the core of the foundation’s grantmaking. One recent example is the 2025 $100,000 research grant to UC Regents/UCSF, which fits its stated focus on reducing pain and human suffering. The foundation’s program language also highlights cancer pain, neuropathic pain, post-operative pain, chronic pain, inflammatory disorders, and endocrine disorders. Translational therapy development is another specific lane. The foundation says it supports all stages of therapy development, including in vitro and in vivo testing, pharmacology, and toxicology. That emphasis aligns with the 2024 $83,500 research grant to UC Regents/UCSF. A third area is hospital-based research at major teaching hospitals. In 2025, it gave $25,993 to Mass General Hospital for research, showing that its support extends beyond a single institution while staying within academic medical research.
The recent grant amounts cluster tightly around the mid-$80,000 range: p25 is $84,375, median is $85,250, and p75 is $86,125. One larger award of $100,000 and one smaller award of $25,993 sit outside that band. The available record shows a repeated relationship with the same recipient over multiple years, which suggests ongoing project support rather than isolated awards. The foundation is not described as an operating funder or donor-advised fund; its giving appears to come from a small asset base of $2,276,697. It also funds individuals, but the recent grants shown here go to institutions.
$126K
$2.3M
$451K
$193K
Most grants fall between $84K and $86K, with a median of $85K.
25th Percentile
$84K
Median
$85K
75th Percentile
$86K
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Notable grantees: UC Regents / UCSF, Mass General Hospital
Grantmaking is concentrated in California: 100% of grants in the provided record went to recipients in the HQ state, and California is also the top state by grant count. The recipient cities shown are San Francisco and Boston, with San Francisco appearing through UCSF and Boston through Mass General Hospital. The country distribution is entirely U.S.-based, with 4 grants in the United States and none shown outside the country.
It funds pain-related biomedical research, especially work on cancer pain, neuropathic pain, post-operative pain, chronic pain, and related inflammatory or endocrine disorders. The foundation also supports therapy development and pain education, but the recent grant record is concentrated in research grants to academic medical centers.
The foundation’s grant sizes are tightly grouped around the mid-$80,000s. The provided distribution shows p25 at $84,375, median at $85,250, and p75 at $86,125, with one recent $100,000 award above that range and one $25,993 award below it.
Yes. UC Regents/UCSF appears in three of the four recent grants, with awards in 2023, 2024, and 2025. That pattern indicates recurring support to the same academic research institution.
The grant record is entirely U.S.-based, and all grants shown went to recipients in California or Massachusetts. California is the top state by grant count, and 100% of the grants in the provided data were made to recipients in the HQ state, California.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UC REGENTS UCSF | SAN FRANCISO, CA | $100,000 | 2025 | RESEARCH GRANT |
| MASS GENERAL HOSPITAL | BOSTON, MA | $25,993 | 2025 | RESERACH GRANT |
| UC REGENTS UCSF | SAN FRANCISO, CA | $83,500 | 2024 | RESEARCH GRANT |
| UC REGENTS UCSF | SAN FRANCISO, CA | $87,000 | 2023 | RESEARCH GRANT |
UC REGENTS UCSF
$100,000RESEARCH GRANT
MASS GENERAL HOSPITAL
$25,993RESERACH GRANT
UC REGENTS UCSF
$83,500RESEARCH GRANT
UC REGENTS UCSF
$87,000RESEARCH GRANT